Cx611-0101

· Tigenix S.A.U.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cx611-0101, covering 2019-04-12 to 2019-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients [Phase 1, Phase 2]